Article | February 7, 2023

Streamlined Clinical Trial Feasibility: The Key That Unlocks The Site-Sponsor Relationship

Source: Cognizant

Determining the feasibility of a site for clinical research is a critical component of the entire trial process. Too often, however, the feasibility process is disjointed, involving multiple disparate systems and rounds of data gathering across sponsors. This commonly results in duplicated work efforts, extended cycle times and discontented site staff who are responsible for answering the same, or similar, questions from multiple sponsors.

A recent research statement by the American Society of Cancer Oncology called the feasibility assessment process inefficient, highlighting both the number of questions in each feasibility survey and their repetitive nature across surveys. ASCO’s research also found that sites spend a median of 264 hours completing feasibility assessments each year—for the entire life sciences industry, this equates to an estimated $1.6 billion and tens of millions of work hours per year.

Ultimately, the inefficiency and strained relationship limits the number and types of studies sponsors and clinical research organizations (CROs) can conduct, raising the cost of developing new treatments and delaying their arrival to market.

Learn how automation and standardization can improve the site-sponsor journey and streamline clinical trial feasibility.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader